Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 15
Original Research
Drug Survival Outcomes Associated with the Real-World Use of Ixekizumab, Secukinumab, Guselkumab, and Adalimumab for the Treatment of Plaque Psoriasis in China: A 52-Week Single-Center Retrospective Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,394 | Dovepress* | 4,762+ | 129 | 4,891 | |
| PubMed Central* | 632 | 361 | 993 | ||
| Totals | 5,394 | 490 | 5,884 | ||
| *Since 20 October 2022 | |||||
View citations on PubMed Central and Google Scholar